SAN DIEGO, California—Resmed, a health technology company focused on sleep, breathing and care delivered in the home, announced its home sleep apnea test, NightOwl, is now available across the United States. NightOwl is an FDA-cleared home sleep apnea test (HSAT) designed to offer health care providers a simplified, accurate and efficient way to diagnose obstructive sleep apnea (OSA) from the comfort of an individual’s home.
SAN DIEGO—Resmed, a global provider in health technology focused on sleep, breathing and care delivered in the home, announced the publication of a landmark meta-analysis in
SAN DIEGO—ResMed announced the launch of the Kontor head strap, an accessory for the 3D camera Apple Vision Pro, that aims to deliver softness and support for extended wear time. The Kontor head strap seeks to blend the company’s ultra-premium materials and allow for further customization of Apple Vision Pro by offering six included modular counterweights.
SAN DIEGO—ResMed Inc. has seen an increased demand for sleep devices and masks, which has helped drive an 11% increase in year-over-year revenue, the company reported in its quarterly results. The company, which specializes in sleep apnea, chronic obstructive pulmonary diseases and other respiratory conditions products, announced the results for its quarter that ended Sept. 30, which is the first quarter of its 2025 fiscal year. The highlights included:
NEW YORK & SAN DIEGO—ResMed, a digital health technologies company providing medical devices for people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases, unveiled its 2030 strategy aiming to drive growth, profitability and shareholder returns at the 2024 Investor Day in New York City.
AKRON, Ohio—ACU-Serve, a provider of health care management solutions, announced the addition of Kyle Neese as senior account executive. With more than eight years of experience in the respiratory care industry, Neese brings expertise and a passion for fostering client partnerships to his new role.
SAN DIEGO—ResMed, a provider of digital health and cloud-connected medical devices that transform care for people with sleep apnea and other chronic respiratory diseases, announced the U.S. launch of the AirFit F40, an ultra-compact, full-face mask offering the comfort of smaller masks without sacrificing performance to help improve sleep apnea therapy compliance.
SAN DIEGO, California—ResMed launched its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP), combined with digital technology to make it easier for health care providers to treat sleep apnea and to help patients start and stay on therapy.
SAN DIEGO—ResMed is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential magnetic interference when magnets are near certain implants and medical devices in the body. This voluntary field correction does not require a return of a mask with magnets unless the patient is contraindicated.
SAN DIEGO—ResMed announced the results of a study on the global burden of Chronic Obstructive Pulmonary Disease (COPD) through 2050. Published in the Journal of the American Medical Association (JAMA) Network Open, the study found that COPD prevalence among those 25 years and older is expected to increase by 23% from 2020 to 2050, with the largest growth projected among women and within low- and middle-income countries.
SAN DIEGO, California—ResMed announced the acquisition of privately held Somnoware, a U.S. sleep and respiratory care diagnostics software.
Nearly every U.S. hospital and physician entity is more likely to refer patients to a post-acute care (PAC) provider that can support electronic data exchange, according to the latest leading independent survey on interoperability, commissioned by Brightree and MatrixCare, wholly owned subsidiaries of ResMed.
A group of AAHomecare member companies aim to support the association’s public policy work by joining the new Legacy corporate partner tier. Companies now supporting the association at the new level are making an annual dues commitment of $125,000; they include Apria & Byram, ResMed & Brightree and Medline.
MARTINSRIED, Germany and LEIPZIG, Germany (August 2, 2022)—ResMed today announced the acquisition of Leipzig-based company mementor; the deal was completed Monday, Aug. 1. With this acquisition, ResMed strengthens its overall sleep portfolio in Germany with a digital solution for insomnia.
SAN DIEGO (June 30, 2022)—ResMed announced the promotion of Lucile Blaise to global president of Sleep & Respiratory Care, effective July 1, 2022.
SAN DIEGO & HILDESHEIM, Germany (June 14, 2022)—ResMed today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German provider of out-of-hospital software solutions for providers in major settings across the care continuum, from Hg, a software and services investor.
AN DIEGO (March 15, 2022)—ResMed announced the results of its 2022 Global Sleep Surveys, in conjunction with National Sleep Awareness Week (March 13-19) and World Sleep Day (March 18). The surveys, conducted in the first quarter of the year, asked nearly 25,000 respondents in 12 countries what’s keeping them up at night and the results aim to build awareness of the critical role good sleep plays in physical and mental health.
SAN DIEGO (August 26, 2021)—ResMed announced the promotion of Bobby Ghoshal to president of ResMed’s software as a service (SaaS) business, effective immediately. Raj Sodhi will be leaving full-time employment at ResMed, effective Sept. 1.
